Physician
Pgvpediatrics, PA
Pgvpediatrics, PA was paid $486K by Medicaid between Sep 2020 and Feb 2022, across 40 billing codes. Its largest line is 99215, doctor's office visit, returning patient (complex) — 18% of everything it billed.
33Billing provider infoPGVPEDIATRICS, PA
DALLAS, TX 75204
DALLAS, TX 75204
33aNPI1447301379assigned 01/16/2007
33bProvider typePediatrics Physician
28Total paid$486K
24GClaims16,482
24DCodes billed40
24AFirst – last monthSep 2020 – Feb 2022
Compared with peers
Next to other Pediatrics Physician providers in Texas
Rank by total paid#510 of 1,136
Median peer was paid$329K
This provider vs. median1.5×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 2,385 | $51K | |
| 2021 | 12,793 | $388K | |
| 2022 | 1,304 | $48K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 18% | 1,163 | 1,032 | $87K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 14% | 930 | 900 | $68K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 12% | 802 | 744 | $60K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 9.6% | 705 | 619 | $47K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 9.3% | 963 | 833 | $45K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 8.8% | 884 | 784 | $43K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 6.6% | 953 | 841 | $32K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 4.2% | 2,847 | 1,025 | $21K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 3.9% | 248 | 241 | $19K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 3.7% | 652 | 619 | $18K |
| S8301 | Infection control supplies, not otherwise specified | 2.2% | 1,609 | 1,347 | $11K |
| 99429 | 1.5% | 231 | 224 | $8K |
28 more codes
| 90461 | 1.3% | 1,305 | $6K | |
| 99381 | 1.2% | 91 | $6K | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 528 | $3K |
| 83655 | <1% | 244 | $2K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 32 | $2K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 47 | $2K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 21 | $2K |
| 99383 | <1% | 15 | $1K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 20 | $1K |
| 99384 | <1% | 12 | $1K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 75 | $976.79 |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 25 | $447.72 |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 30 | $389.20 |
| S3620 | Newborn metabolic screening panel, includes test kit, postage and the laboratory tests specified by the state for inclusion in this panel (e.g., galactose; hemoglobin, electrophoresis; hydroxyprogesterone, 17-d; phenylalanine (pku); and thyroxine, total) | <1% | 21 | $350.00 |
| 83789 | <1% | 21 | $202.50 | |
| 99072 | <1% | 144 | $50.00 | |
| 84030 | <1% | 21 | $46.20 | |
| 90686 | <1% | 296 | $17.51 | |
| 90680 | <1% | 159 | $0.01 | |
| 90716 | <1% | 140 | $0.01 | |
| 90744 | <1% | 184 | $0.01 | |
| 90670 | <1% | 386 | $0.01 | |
| 90707 | <1% | 156 | $0.01 | |
| 90698 | 0% | 261 | $0.00 | |
| 90696 | 0% | 12 | $0.00 | |
| 90633 | 0% | 180 | $0.00 | |
| 90700 | 0% | 54 | $0.00 | |
| 90648 | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialAGRAWAL, ANURADHA (PRESIDENT)